384 related articles for article (PubMed ID: 10746849)
1. The risk of premalignant and malignant pathology in endometrial polyps.
Bakour SH; Khan KS; Gupta JK
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):317-20. PubMed ID: 10746849
[TBL] [Abstract][Full Text] [Related]
2. Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies.
Wang JH; Zhao J; Lin J
J Minim Invasive Gynecol; 2010; 17(1):53-8. PubMed ID: 20129333
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
4. Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy.
Antunes A; Costa-Paiva L; Arthuso M; Costa JV; Pinto-Neto AM
Maturitas; 2007 Aug; 57(4):415-21. PubMed ID: 17587515
[TBL] [Abstract][Full Text] [Related]
5. Are endometrial polyps true cancer precursors?
Perri T; Rahimi K; Ramanakumar AV; Wou K; Pilavdzic D; Franco EL; Gotlieb WH; Ferenczy A
Am J Obstet Gynecol; 2010 Sep; 203(3):232.e1-6. PubMed ID: 20478550
[TBL] [Abstract][Full Text] [Related]
6. Endometrial hyperplasia and carcinoma in endometrial polyps: clinicopathologic and follow-up findings.
Mittal K; Da Costa D
Int J Gynecol Pathol; 2008 Jan; 27(1):45-8. PubMed ID: 18156974
[TBL] [Abstract][Full Text] [Related]
7. Malignancy in endometrial polyps: a 12-year experience.
Baiocchi G; Manci N; Pazzaglia M; Giannone L; Burnelli L; Giannone E; Fratini D; Di Renzo GC
Am J Obstet Gynecol; 2009 Nov; 201(5):462.e1-4. PubMed ID: 19632664
[TBL] [Abstract][Full Text] [Related]
8. Clinical parameters linked with malignancy in endometrial polyps.
Gregoriou O; Konidaris S; Vrachnis N; Bakalianou K; Salakos N; Papadias K; Kondi-Pafiti A; Creatsas G
Climacteric; 2009 Oct; 12(5):454-8. PubMed ID: 19591006
[TBL] [Abstract][Full Text] [Related]
9. Risk and predictors of malignancy in women with endometrial polyps.
Wethington SL; Herzog TJ; Burke WM; Sun X; Lerner JP; Lewin SN; Wright JD
Ann Surg Oncol; 2011 Dec; 18(13):3819-23. PubMed ID: 21701931
[TBL] [Abstract][Full Text] [Related]
10. Validation of hysteroscopic view in cases of endometrial hyperplasia and cancer in patients with abnormal uterine bleeding.
Lasmar RB; Barrozo PR; de Oliveira MA; Coutinho ES; Dias R
J Minim Invasive Gynecol; 2006; 13(5):409-12. PubMed ID: 16962523
[TBL] [Abstract][Full Text] [Related]
11. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study.
Ferrazzi E; Zupi E; Leone FP; Savelli L; Omodei U; Moscarini M; Barbieri M; Cammareri G; Capobianco G; Cicinelli E; Coccia ME; Donarini G; Fiore S; Litta P; Sideri M; Solima E; Spazzini D; Testa AC; Vignali M
Am J Obstet Gynecol; 2009 Mar; 200(3):235.e1-6. PubMed ID: 19027096
[TBL] [Abstract][Full Text] [Related]
12. Endometrial hyperplasia involving endometrial polyps: report of a series and discussion of the significance in an endometrial biopsy specimen.
Kelly P; Dobbs SP; McCluggage WG
BJOG; 2007 Aug; 114(8):944-50. PubMed ID: 17565613
[TBL] [Abstract][Full Text] [Related]
13. The risk of premalignant and malignant pathology in endometrial polyps: should every polyp be resected?
Papadia A; Gerbaldo D; Fulcheri E; Ragni N; Menoni S; Zanardi S; Brusacà B
Minerva Ginecol; 2007 Apr; 59(2):117-24. PubMed ID: 17505453
[TBL] [Abstract][Full Text] [Related]
14. Thin-layer cytology and histopathology in the evaluation of abnormal uterine bleeding.
Garcia F; Barker B; Davis J; Shelton T; Harrigill K; Schalk N; Meyer J; Hatch K
J Reprod Med; 2003 Nov; 48(11):882-8. PubMed ID: 14686021
[TBL] [Abstract][Full Text] [Related]
15. Hysterscopic Resection of Premalignant and Malignant Endometrial Polyps: Is it a Safe Alternative to Hysterectomy?
Elyashiv O; Sagiv R; Kerner R; Keidar R; Menczer J; Levy T
J Minim Invasive Gynecol; 2017; 24(7):1200-1203. PubMed ID: 28802955
[TBL] [Abstract][Full Text] [Related]
16. Recurrent postmenopausal bleeding: a prospective cohort study.
Smith PP; O'Connor S; Gupta J; Clark TJ
J Minim Invasive Gynecol; 2014; 21(5):799-803. PubMed ID: 24681065
[TBL] [Abstract][Full Text] [Related]
17. Management of abnormal uterine bleeding and the pathology of endometrial hyperplasia.
Espindola D; Kennedy KA; Fischer EG
Obstet Gynecol Clin North Am; 2007 Dec; 34(4):717-37, ix. PubMed ID: 18061866
[TBL] [Abstract][Full Text] [Related]
18. Abnormal uterine bleeding. Diagnostic value of hysteroscopy.
Madan SM; Al-Jufairi ZA
Saudi Med J; 2001 Feb; 22(2):153-6. PubMed ID: 11299412
[TBL] [Abstract][Full Text] [Related]
19. Can the endometrial thickness as measured by trans-vaginal sonography be used to exclude polyps or hyperplasia in pre-menopausal patients with abnormal uterine bleeding?
Dueholm M; Jensen ML; Laursen H; Kracht P
Acta Obstet Gynecol Scand; 2001 Jul; 80(7):645-51. PubMed ID: 11437723
[TBL] [Abstract][Full Text] [Related]
20. Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics.
Costa-Paiva L; Godoy CE; Antunes A; Caseiro JD; Arthuso M; Pinto-Neto AM
Menopause; 2011 Dec; 18(12):1278-82. PubMed ID: 21926931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
